Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE0657 in CHF Patients With Cheyne-Stokes Breathing
2007-002172-34Phase 2Completed
- Sponsor
- Sanofi
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) and Cheyne-Stokes respiration (CSR) comparing AVE0657 with Placebo (2 arms). Primary endpoint: Apnea-Hypopnea Index change from baseline to Day 2. Started Aug 2007; status: completed.
02
Drugs
AVE-0657
03
Conditions
heart failure (HF)Cheyne-Stokes respiration (CSR)
Beyond the preview
Go deeper on 2007-002172-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002172-34.